Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04432883 · ClinicalTrials.gov registry record · NA

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

A NA study of Stroke and Aphasia, sponsored by University of New Mexi.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04432883 is a NA study of Stroke and Aphasia that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04432883, a NA study of Stroke and Aphasia, is actively recruiting participants, sponsored by University of New Mexi.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.

Conditions Studied

Interventions

  • DEVICE Active Comparator: Experimental: Active cathodal tDCS + language training
  • BEHAVIORAL Sham Comparator: Placebo cathodal tDCS + Speech and language

Study Locations (1)

New Mexico

  • University of New Mexico Center for Brain Recovery and Repair - Albuquerque

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-10-18
Est. Completion 2027-04-30
Phase NA

Sponsor

University of New Mexi

76 total trials

What the Registry Record Tells You About NCT04432883

The ClinicalTrials.gov registry entry for NCT04432883 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of New Mexi, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Active Comparator: Experimental: Active cathodal tDCS + language training is the first listed.

NCT04432883 reports 1 study location spanning 1 distinct geographic area - top geographies include New Mexico.

Frequently Asked Questions

What is clinical trial NCT04432883 about?

NCT04432883 is a clinical study titled "Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.". 62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysi...

What is the current status of trial NCT04432883?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-10-18. Estimated completion is 2027-04-30.

What conditions does trial NCT04432883 study?

This clinical trial studies the following conditions: Stroke, Aphasia.

What interventions are being tested in trial NCT04432883?

The interventions under investigation include: Active Comparator: Experimental: Active cathodal tDCS + language training (DEVICE), Sham Comparator: Placebo cathodal tDCS + Speech and language (BEHAVIORAL).

Who is sponsoring clinical trial NCT04432883?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04432883 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.